486 related articles for article (PubMed ID: 1978842)
1. NSAID-induced gastrointestinal damage. A critical review of prophylaxis and therapy.
McCarthy DM
J Clin Gastroenterol; 1990; 12 Suppl 2():S13-20. PubMed ID: 1978842
[TBL] [Abstract][Full Text] [Related]
2. Prevention and treatment of ulcers induced by nonsteroidal anti-inflammatory drugs: an update.
Dajani EZ; Agrawal NM
J Physiol Pharmacol; 1995 Mar; 46(1):3-16. PubMed ID: 7599335
[TBL] [Abstract][Full Text] [Related]
3. Prevention and treatment of gastrointestinal symptoms and complications due to NSAIDs.
McCarthy DM
Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):755-73. PubMed ID: 11566039
[TBL] [Abstract][Full Text] [Related]
4. Prevention and treatment of ulcers induced by nonsteroidal anti-inflammatory drugs.
Agrawal NM; Dajani EZ
J Assoc Acad Minor Phys; 1992; 3(4):142-8. PubMed ID: 1392409
[TBL] [Abstract][Full Text] [Related]
5. Drugs for treatment of peptic ulcers.
Dajani EZ; Trotman BW
J Assoc Acad Minor Phys; 1992; 3(3):78-88. PubMed ID: 1353999
[TBL] [Abstract][Full Text] [Related]
6. [Prevention of NSAID induced gastroduodenal ulcers].
Hansen JM; Bytzer P
Ugeskr Laeger; 2001 Oct; 163(44):6103-5. PubMed ID: 11715151
[TBL] [Abstract][Full Text] [Related]
7. Nonsteroidal anti-inflammatory drugs: add an anti-ulcer drug for patients at high risk only. Always limit the dose and duration of treatment with NSAIDs.
Prescrire Int; 2011 Sep; 20(119):216-9. PubMed ID: 21954519
[TBL] [Abstract][Full Text] [Related]
8. Management of NSAID-induced ulcer disease.
Clearfield HR
Am Fam Physician; 1992 Jan; 45(1):255-8. PubMed ID: 1728095
[TBL] [Abstract][Full Text] [Related]
9. An etiologic approach to management of duodenal and gastric ulcers.
Rex DK
J Fam Pract; 1994 Jan; 38(1):60-7. PubMed ID: 8289053
[TBL] [Abstract][Full Text] [Related]
10. Treatment of nonsteroidal anti-inflammatory drug-induced gastropathy.
Miller DR
Clin Pharm; 1992 Aug; 11(8):690-704. PubMed ID: 1511542
[TBL] [Abstract][Full Text] [Related]
11. Role of acid suppressants in prophylaxis of NSAID damage.
Chan FK; Sung JJ
Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):433-45. PubMed ID: 11403537
[TBL] [Abstract][Full Text] [Related]
12. Gastroprotective therapy and risk of gastrointestinal ulcers: risk reduction by COX-2 therapy.
Wolfe F; Anderson J; Burke TA; Arguelles LM; Pettitt D
J Rheumatol; 2002 Mar; 29(3):467-73. PubMed ID: 11908558
[TBL] [Abstract][Full Text] [Related]
13. Nonsteroidal antiinflammatory drug-induced gastroduodenal lesions: prophylaxis and treatment.
Zfass AM; McHenry L; Sanyal AJ
Gastroenterologist; 1993 Jun; 1(2):165-9. PubMed ID: 8049889
[TBL] [Abstract][Full Text] [Related]
14. Medical treatment of peptic ulcers.
Deveney CW; Deveney KE
Surg Annu; 1985; 17():219-33. PubMed ID: 3883541
[TBL] [Abstract][Full Text] [Related]
15. Peptic ulcers in the elderly: unique features and management.
Freston MS; Freston JW
Geriatrics; 1990 Jan; 45(1):39-42, 45. PubMed ID: 2403956
[TBL] [Abstract][Full Text] [Related]
16. Anti-inflammatories and gastroduodenal damage: therapeutic options.
Agrawal NM
Eur J Rheumatol Inflamm; 1993; 13(1):17-24. PubMed ID: 7821335
[TBL] [Abstract][Full Text] [Related]
17. The therapeutic efficacy of misoprostol in peptic ulcer disease.
Watkinson G; Hopkins A; Akbar FA
Postgrad Med J; 1988; 64 Suppl 1():60-77. PubMed ID: 3138682
[TBL] [Abstract][Full Text] [Related]
18. NSAID-induced gastrointestinal toxicity.
Simon LS; Goodman T
Bull Rheum Dis; 1995 May; 44(3):1-5. PubMed ID: 7767404
[TBL] [Abstract][Full Text] [Related]
19. Management of nonsteroidal anti-inflammatory drug-induced gastroduodenal disease by acid suppression.
Lad R; Armstrong D
Can J Gastroenterol; 1999 Mar; 13(2):135-42. PubMed ID: 10203432
[TBL] [Abstract][Full Text] [Related]
20. Treatment and prevention of NSAID induced gastroduodenal mucosal damage.
Agrawal NM; Saggioro A
J Rheumatol Suppl; 1991 Mar; 28():15-8. PubMed ID: 1674754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
